200 related articles for article (PubMed ID: 25302990)
41. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.
Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M
Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719
[TBL] [Abstract][Full Text] [Related]
42. Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma.
Ross JL; Chen Z; Herting CJ; Grabovska Y; Szulzewsky F; Puigdelloses M; Monterroza L; Switchenko J; Wadhwani NR; Cimino PJ; Mackay A; Jones C; Read RD; MacDonald TJ; Schniederjan M; Becher OJ; Hambardzumyan D
Brain; 2021 Feb; 144(1):53-69. PubMed ID: 33300045
[TBL] [Abstract][Full Text] [Related]
43. B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.
Wu J; Li L; Jiang G; Zhan H; Wang N
Int J Oncol; 2016 Dec; 49(6):2471-2479. PubMed ID: 27748795
[TBL] [Abstract][Full Text] [Related]
44. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
[TBL] [Abstract][Full Text] [Related]
45. Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.
Gressot LV; Doucette T; Yang Y; Fuller GN; Manyam G; Rao A; Latha K; Rao G
Oncotarget; 2017 Feb; 8(8):12695-12704. PubMed ID: 27074575
[TBL] [Abstract][Full Text] [Related]
46. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
[TBL] [Abstract][Full Text] [Related]
47. Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.
Han X; Osuntokun B; Benight N; Loesch K; Frank SJ; Denson LA
Am J Pathol; 2006 Dec; 169(6):1999-2013. PubMed ID: 17148664
[TBL] [Abstract][Full Text] [Related]
48. Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation.
Kundumani-Sridharan V; Wang D; Karpurapu M; Liu Z; Zhang C; Dronadula N; Rao GN
Am J Pathol; 2007 Oct; 171(4):1381-94. PubMed ID: 17823285
[TBL] [Abstract][Full Text] [Related]
49. IGF-1 stimulated upregulation of cyclin D1 is mediated via STAT5 signaling pathway in neuronal cells.
Kalita A; Gupta S; Singh P; Surolia A; Banerjee K
IUBMB Life; 2013 May; 65(5):462-71. PubMed ID: 23504816
[TBL] [Abstract][Full Text] [Related]
50. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation.
Jiang Y; Boije M; Westermark B; Uhrbom L
Neoplasia; 2011 Jun; 13(6):492-503. PubMed ID: 21677873
[TBL] [Abstract][Full Text] [Related]
51. Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting.
Koppikar P; Lui VW; Man D; Xi S; Chai RL; Nelson E; Tobey AB; Grandis JR
Clin Cancer Res; 2008 Dec; 14(23):7682-90. PubMed ID: 19047094
[TBL] [Abstract][Full Text] [Related]
52. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
53. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
Shimizu A; O'Brien KP; Sjöblom T; Pietras K; Buchdunger E; Collins VP; Heldin CH; Dumanski JP; Ostman A
Cancer Res; 1999 Aug; 59(15):3719-23. PubMed ID: 10446987
[TBL] [Abstract][Full Text] [Related]
54. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
[TBL] [Abstract][Full Text] [Related]
55. Genetic background determines if Stat5b suppresses or enhances murine hepatocarcinogenesis.
Oberley CC; Bilger A; Drinkwater NR
Mol Carcinog; 2015 Oct; 54(10):959-70. PubMed ID: 24838184
[TBL] [Abstract][Full Text] [Related]
56. Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis.
Clodfelter KH; Holloway MG; Hodor P; Park SH; Ray WJ; Waxman DJ
Mol Endocrinol; 2006 Jun; 20(6):1333-51. PubMed ID: 16469768
[TBL] [Abstract][Full Text] [Related]
57. The Fyn-Stat5 cascade is required for Fcγ receptor-mediated mast cell function.
Paranjape A; Haque TT; Kiwanuka KN; Qayum AA; Barnstein BO; Finkelman FD; Nigrovic PA; Ryan JJ
Cell Immunol; 2020 Oct; 356():104134. PubMed ID: 32862025
[TBL] [Abstract][Full Text] [Related]
58. Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4alpha.
Holloway MG; Laz EV; Waxman DJ
Mol Endocrinol; 2006 Mar; 20(3):647-60. PubMed ID: 16239260
[TBL] [Abstract][Full Text] [Related]
59. RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis.
Jiang Y; Sheng H; Meng L; Yue H; Li B; Zhang A; Dong Y; Liu Y
World J Surg Oncol; 2017 Jan; 15(1):9. PubMed ID: 28061901
[TBL] [Abstract][Full Text] [Related]
60. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
